Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Campaign-ready series of recombinant adeno-associated virus (rAAV) complementing plasmids

US Patent 11884926 · Granted Jan 30, 2024

Estimated economic value: $1,530,000

Assignee

Inventors

View full patent text on Google Patents →